Advertisement

Topics

OncLive® Presents State of the Science Summit™: Advanced Non-Small Cell Lung Cancer

11:12 EST 8 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The meeting will present the latest developments in lung cancer research, treatment and management OncLive®, a leading digital provider of resources and information to oncology professionals will host the latest Stat...

Other Sources for this Article

OncLive® Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

NEXT ARTICLE

More From BioPortfolio on "OncLive® Presents State of the Science Summit™: Advanced Non-Small Cell Lung Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...